Atlas Trials

Effects of Early Use of Nitazoxanide in Patients With COVID-19

Clinical trial NCT04552483 · COMPLETED

Trial details

NCT number
NCT04552483
Sponsor
Universidade Federal do Rio de Janeiro
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19Coronavirus
Start date
2020-06-08
Primary completion
2020-08-20
Enrollment
392

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.